Login / Signup

Novel naturally occurring autoantibodies attenuate α-synuclein pathology in a mouse model of Parkinson's disease.

Yiming LiTao WangLanxia MengLei JinCongcong LiuYangqiu LiangLin RenYang LiuYanshuang LiuShuang LiuTete LiYanqi LiangXiaoping ChenZhentao Zhang
Published in: Neuropathology and applied neurobiology (2022)
P21 and P22 attenuate α-synuclein pathology and are promising candidates for PD treatment.
Keyphrases
  • mouse model
  • systemic lupus erythematosus
  • replacement therapy